Back
EHRA Premium Access

Prognosis of cardiac sarcoidosis in patients with implantable cardioverter defibrillator -primary versus secondary prevention-

Session: Poster session 3 - Sudden cardiac death and implantable defibrillators
Topic: Primary prevention (Sudden cardiac death and implantable defibrillators)
Speaker: Doctor M. Nakano (Chiba, JP)
Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)
0 follower

16 more presentations in this session

Long-term effectiveness and complications of ICDs in patients with hypertrophic cardiomyopathy

Speaker: Miss N. Calvo Galiano (Zaragoza, ES)

Access
Abstract
Like
Thumbnail

Prophylactic cardioverter-defibrillator implantation in systolic heart failure: does the aetiology of cardiomyopathy matter?

Speaker: Miss M. Braga (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Performance of sudden cardiac death risk score at the time of device replacement for patients with hypertrophic cardiomyopathy

Speaker: Doctor M. Biffi (Bologna, IT)

Access
Abstract
Slides
Like
Thumbnail

Predictors of future implantable cardioverter-defibrillators appropriate therapies in patients undergoing generator replacement: who still benefiting from implantable cardioverter-defibrillators?

Speaker: Doctor M. Madeira (Coimbra, PT)

Access
Abstract
Slides
Like
Thumbnail

Influence of beta-blocker therapy on the incidence and on the timing of heart failure decompensation after an ICD shock.

Speaker: Associate Professor J. Jimenez-Candil (Salamanca, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 3 - Sudden cardiac death and implantable defibrillators

Speakers: Doctor M. Nakano, Miss N. Calvo Galiano, Miss M. Braga, Doctor M. Biffi, Doctor M. Madeira...
Access
Like
Thumbnail

About the event

Image

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources